Literature DB >> 20471050

The neuro-ophthalmology of mitochondrial disease.

J Alexander Fraser1, Valérie Biousse, Nancy J Newman.   

Abstract

Mitochondrial diseases frequently manifest neuro-ophthalmologic symptoms and signs. Because of the predilection of mitochondrial disorders to involve the optic nerves, extraocular muscles, retina, and even the retrochiasmal visual pathways, the ophthalmologist is often the first physician to be consulted. Disorders caused by mitochondrial dysfunction can result from abnormalities in either the mitochondrial DNA or in nuclear genes which encode mitochondrial proteins. Inheritance of these mutations will follow patterns specific to their somatic or mitochondrial genetics. Genotype-phenotype correlations are inconstant, and considerable overlap may occur among these syndromes. The diagnostic approach to the patient with suspected mitochondrial disease entails a detailed personal and family history, careful ophthalmic, neurologic, and systemic examination, directed investigations, and attention to potentially life-threatening sequelae. Although curative treatments for mitochondrial disorders are currently lacking, exciting research advances are being made, particularly in the area of gene therapy. Leber hereditary optic neuropathy, with its window of opportunity for timely intervention and its accessibility to directed therapy, offers a unique model to study future therapeutic interventions. Most patients and their relatives benefit from informed genetic counseling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471050      PMCID: PMC2989385          DOI: 10.1016/j.survophthal.2009.10.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  257 in total

Review 1.  Exercise and training in mitochondrial myopathies.

Authors:  Tanja Taivassalo; Ronald G Haller
Journal:  Med Sci Sports Exerc       Date:  2005-12       Impact factor: 5.411

Review 2.  OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape.

Authors:  Massimo Zeviani
Journal:  Brain       Date:  2008-02       Impact factor: 13.501

3.  Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation.

Authors:  Valerio Carelli; Alessandra Baracca; Silvia Barogi; Francesco Pallotti; Maria Lucia Valentino; Pasquale Montagna; Massimo Zeviani; Antonella Pini; Giorgio Lenaz; Agostino Baruzzi; Giancarlo Solaini
Journal:  Arch Neurol       Date:  2002-02

4.  Complicated hereditary spastic paraplegia with peripheral neuropathy, optic atrophy and mental retardation.

Authors:  S Miyama; K Arimoto; S Kimiya; H Tomi
Journal:  Neuropediatrics       Date:  2000-08       Impact factor: 1.947

5.  Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.

Authors:  Amy C Cohn; Carmel Toomes; Catherine Potter; Katherine V Towns; Alex W Hewitt; Chris F Inglehearn; Jamie E Craig; David A Mackey
Journal:  Am J Ophthalmol       Date:  2007-02-15       Impact factor: 5.258

6.  Neuropsychological status of mitochondrial encephalomyopathies.

Authors:  C J Lang; P Brenner; D Heub; A Engelhardt; H Reichmann; P Seibel; B Neundörfer
Journal:  Eur J Neurol       Date:  1995-07       Impact factor: 6.089

7.  Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?

Authors:  P F Chinnery; R M Andrews; D M Turnbull; N N Howell
Journal:  Am J Med Genet       Date:  2001-01-22

8.  OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy.

Authors:  Jian Han; Angela J Thompson-Lowrey; Alyson Reiss; Vladimir Mayorov; Haomiao Jia; Valerie Biousse; Nancy J Newman; Michael D Brown
Journal:  Genet Med       Date:  2006-04       Impact factor: 8.822

9.  Gene-environment interactions in Leber hereditary optic neuropathy.

Authors:  Matthew Anthony Kirkman; Patrick Yu-Wai-Man; Alex Korsten; Miriam Leonhardt; Konstantin Dimitriadis; Ireneaus F De Coo; Thomas Klopstock; Patrick Francis Chinnery
Journal:  Brain       Date:  2009-06-12       Impact factor: 13.501

10.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.

Authors:  Patrizia Amati-Bonneau; Maria Lucia Valentino; Pascal Reynier; Maria Esther Gallardo; Belén Bornstein; Anne Boissière; Yolanda Campos; Henry Rivera; Jesús González de la Aleja; Rosanna Carroccia; Luisa Iommarini; Pierre Labauge; Dominique Figarella-Branger; Pascale Marcorelles; Alain Furby; Katell Beauvais; Franck Letournel; Rocco Liguori; Chiara La Morgia; Pasquale Montagna; Maria Liguori; Claudia Zanna; Michela Rugolo; Andrea Cossarizza; Bernd Wissinger; Christophe Verny; Robert Schwarzenbacher; Miguel Angel Martín; Joaquín Arenas; Carmen Ayuso; Rafael Garesse; Guy Lenaers; Dominique Bonneau; Valerio Carelli
Journal:  Brain       Date:  2007-12-24       Impact factor: 13.501

View more
  79 in total

1.  [Leber's hereditary optic neuropathy].

Authors:  B Leo-Kottler; B Wissinger
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

2.  [Bilateral visual deterioration in excessive tobacco and alcohol consumption].

Authors:  M Cyrus-Hajmassy
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

3.  Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

Authors:  Huajin Li; Evan M Jones; Hui Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Rui Chen; Fangtian Dong; Ruifang Sui
Journal:  Ophthalmic Genet       Date:  2018-06-28       Impact factor: 1.803

4.  Treatment of Leber hereditary optic neuropathy.

Authors:  Nancy J Newman
Journal:  Brain       Date:  2011-08-22       Impact factor: 13.501

5.  Therapeutic strategies for Leber's hereditary optic neuropathy: A current update.

Authors:  Nuri Gueven; Dharmesh Faldu
Journal:  Intractable Rare Dis Res       Date:  2013-11

6.  [LHON-Treatment option despite poor initial visual acuity?]

Authors:  A Rickmann; L Wocker; L-J Damm; C Ivanescu; P Szurman; N Pérez Guerra
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

7.  Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Arwin M Valencia; Douglas R Lazzaro; Fayez Bany-Mohammed; Jacob V Aranda
Journal:  React Oxyg Species (Apex)       Date:  2017-01

Review 8.  Mitochondrial disorders and the eye.

Authors:  Samantha A Schrier; Marni J Falk
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

9.  Long-term evaluation of Leber's hereditary optic neuropathy-like symptoms in rotenone administered rats.

Authors:  Li Zhang; Laura Liu; Ann L Philip; Juan C Martinez; Juan C Guttierez; Mathieu Marella; Gaurav Patki; Akemi Matsuno-Yagi; Takao Yagi; Biju B Thomas
Journal:  Neurosci Lett       Date:  2014-12-03       Impact factor: 3.046

10.  Bilateral vision loss due to Leber's hereditary optic neuropathy after long-term alcohol, nicotine and drug abuse.

Authors:  Johanna Maass; Egbert Matthé
Journal:  Doc Ophthalmol       Date:  2018-01-25       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.